| LGSCX | VSMAX | LGSCX / VSMAX | |
| Total Expense Ratio | 1.30 | 0.05 | 2,600% |
| Annual Report Gross Expense Ratio | 1.62 | 0.05 | 3,240% |
| Fund Existence | 23 years | 25 years | - |
| Gain YTD | 12.924 | 2.248 | 575% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 120M | 162B | 0% |
| Annual Yield % from dividends | 0.31 | 1.34 | 23% |
| Returns for 1 year | 4.61 | -0.53 | -873% |
| Returns for 3 years | 27.89 | 29.85 | 93% |
| Returns for 5 years | 20.28 | 39.21 | 52% |
| Returns for 10 years | 12.04 | 122.28 | 10% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PHPIX | 30.67 | N/A | N/A |
| ProFunds Pharmaceuticals UltraSector Inv | |||
| NSNRX | 51.37 | N/A | N/A |
| Neuberger Berman Small Cap Growth R3 | |||
| EVSIX | 27.42 | N/A | N/A |
| Allspring Disciplined US Core Inst | |||
| CBEJX | 11.24 | N/A | N/A |
| Allspring Large Cap Value CL R6 | |||
| JCNAX | 27.96 | -0.10 | -0.36% |
| Janus Henderson Contrarian A | |||